Expertise in
5
conditions

Dr. Daniel Garber

Sleep Medicine
Forsyth Medical Group LLC
2323 Concord Lake Rd, 
Concord, NC 
Offers Telehealth
Expertise in
5
conditions
Forsyth Medical Group LLC
2323 Concord Lake Rd, 
Concord, NC 

Overview

Daniel Garber is a Sleep Medicine provider in Concord, North Carolina. Dr. Garber is highly rated in 5 conditions, according to our data. His top areas of expertise are Obstructive Sleep Apnea, Drowsiness, Excessive Daytime Sleepiness, and Insomnia.

His clinical research consists of participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Sleep Medicine

Licenses

Psychiatry & Neurology in NC

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 1 Less Insurance Carrier -

Locations

Forsyth Medical Group LLC
2323 Concord Lake Rd, Concord, NC 28025
Other Locations
Carolinas Sleep Specialists PA
920 Copperfield Blvd NE, Concord, NC 28025

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
Enrollment Status: Completed
Publish Date: January 13, 2025
Intervention Type: Drug
Study Drug: SUVN-G3031
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled, Multiple Rising Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-994 in Patients With Narcolepsy With or Without Cataplexy (Narcolepsy Type 1 or Narcolepsy Type 2)
A Randomized, Double-Blind, Placebo-Controlled, Multiple Rising Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-994 in Patients With Narcolepsy With or Without Cataplexy (Narcolepsy Type 1 or Narcolepsy Type 2)
Enrollment Status: Terminated
Publish Date: October 29, 2024
Intervention Type: Drug
Study Drug: TAK-994
Study Phase: Phase 2
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug
Study Phase: Phase 3
A Dose-Blind Extension Study With Double-blind, Placebo-Controlled, Randomized Withdrawal Period to Evaluate the Safety and Explore the Pharmacokinetics and Pharmacodynamics of TAK-994 in Adults With Narcolepsy With Cataplexy (Narcolepsy Type 1)
A Dose-Blind Extension Study With Double-blind, Placebo-Controlled, Randomized Withdrawal Period to Evaluate the Safety and Explore the Pharmacokinetics and Pharmacodynamics of TAK-994 in Adults With Narcolepsy With Cataplexy (Narcolepsy Type 1)
Enrollment Status: Terminated
Publish Date: December 26, 2023
Intervention Type: Drug
Study Phase: Phase 2
A 6-Month Multicenter, Open-Labelled Extension of the Clinical Trial NLS-1021 in Narcoleptic Patients With and Without Cataplexy
A 6-Month Multicenter, Open-Labelled Extension of the Clinical Trial NLS-1021 in Narcoleptic Patients With and Without Cataplexy
Enrollment Status: Completed
Publish Date: March 13, 2023
Intervention Type: Drug
Study Drug: Mazindol
Study Phase: Phase 2
A Four-week, Double-blind, Placebo-controlled, Randomized, Multicenter, Parallel-group Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in Adults for the Treatment of Narcolepsy
A Four-week, Double-blind, Placebo-controlled, Randomized, Multicenter, Parallel-group Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in Adults for the Treatment of Narcolepsy
Enrollment Status: Completed
Publish Date: August 12, 2022
Intervention Type: Drug
Study Drug: Mazindol
Study Phase: Phase 2
A Study to Assess the Frequency and Characteristics of Wake and Sleep State Transitions Over Multiple Nights in Subjects With Narcolepsy Type 1 Compared With Healthy Subjects Using a Portable Electroencephalogram Device
A Study to Assess the Frequency and Characteristics of Wake and Sleep State Transitions Over Multiple Nights in Subjects With Narcolepsy Type 1 Compared With Healthy Subjects Using a Portable Electroencephalogram Device
Enrollment Status: Completed
Publish Date: May 07, 2021
Intervention Type: Device
View 6 Less Clinical Trials
Similar Doctors
Iyad H. Asaad
Expertise in
16
conditions
Dr. Iyad H. Asaad
Sleep Medicine | Intensive Care Medicine | Pulmonary Medicine
Expertise in
16
conditions
Dr. Iyad H. Asaad
Sleep Medicine | Intensive Care Medicine | Pulmonary Medicine

Atrium Health Pulmonology & Sleep Medicine

1090 Northeast Gateway Court, Suite 201, 
Concord, NC 
 (0.1 miles away)
704-403-7770
Experience:
30+ years
Languages Spoken:
English, Arabic
See accepted insurances
Accepting New Patients
Offers Telehealth

Iyad Asaad is a Sleep Medicine specialist and an Intensive Care Medicine provider in Concord, North Carolina. Dr. Asaad has been practicing medicine for over 30 years is highly rated in 16 conditions, according to our data. His top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Asthma in Children, Pleural Effusion, and Advanced Bronchoscopy. Dr. Asaad is currently accepting new patients.

Urvi G. Desai
Expertise in
40
conditions
Dr. Urvi G. Desai
Sleep Medicine | Neuromusculoskeletal Medicine
Expertise in
40
conditions
Dr. Urvi G. Desai
Sleep Medicine | Neuromusculoskeletal Medicine

Atrium Health Neurology Specialty Care, A Facility Of Carolinas Medical Center

1010 Edgehill Road N., 
Charlotte, NC 
 (21.4 miles away)
704-468-0101
Languages Spoken:
English, Gujarati , Hindi
See accepted insurances
Accepting New Patients
Offers Telehealth

Urvi Desai is a Neuromusculoskeletal Medicine specialist and a Sleep Medicine provider in Charlotte, North Carolina. Dr. Desai is highly rated in 40 conditions, according to our data. Her top areas of expertise are Chronic Inflammatory Demyelinating Polyneuropathy, Dysferlinopathy, Facioscapulohumeral Muscular Dystrophy (FSHD), and Myasthenia Gravis. Dr. Desai is currently accepting new patients.

Christopher S. Connelly
Expertise in
11
conditions
Dr. Christopher S. Connelly
Sleep Medicine
Expertise in
11
conditions
Dr. Christopher S. Connelly
Sleep Medicine

Atrium Health Neurology

315 Medical Park Drive, Suite 202, 
Concord, NC 
 (0.1 miles away)
704-468-0101
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Christopher Connelly is a Sleep Medicine provider in Concord, North Carolina. Dr. Connelly is highly rated in 11 conditions, according to our data. His top areas of expertise are Apraxia, Multiple Sclerosis (MS), Alzheimer's Disease, and Peripheral Neuropathy. Dr. Connelly is currently accepting new patients.

Frequently Asked Questions about Dr. Daniel Garber

How do I make an appointment with Dr. Daniel Garber?

You can book an appointment with Dr. Daniel Garber by calling their office at 704-707-4120. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Daniel Garber a top-rated expert for Obstructive Sleep Apnea?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Daniel Garber is classified as an Advanced expert for Obstructive Sleep Apnea, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Daniel Garber specialize in?

While Dr. Daniel Garber is a Sleep Medicine, they have specific expertise in Obstructive Sleep Apnea, Drowsiness, and Excessive Daytime Sleepiness. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Sleep Medicine.

Does Dr. Daniel Garber accept my insurance?

Dr. Daniel Garber accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 704-707-4120 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Garber's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile